Your browser doesn't support javascript.
loading
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
Wang, Yawen; Xue, Hongwei; Song, Wei; Xiao, Shuxin; Jing, Fanjing; Dong, Tieying; Wang, Lili.
Afiliação
  • Wang Y; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Xue H; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Song W; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Xiao S; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Jing F; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Dong T; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Wang L; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Hematol Oncol ; 40(4): 617-625, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35165928

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies Limite: Aged / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies Limite: Aged / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China